Navigation Links
Amylin Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results
Date:2/6/2012

included a $15.0 million milestone payment from Lilly in connection with the launch of BYDUREON in the European Union in July, compared to $17.7 million for the same period in 2010, which included $10 million in milestone revenue earned upon the launch of BYETTA in Japan.

Selling, general and administrative expenses decreased to $271.2 million for the twelve months ended December 31, 2011 from $276.9 million for the same period in 2010. The decrease primarily reflects reduced business infrastructure spending resulting from continued efforts to drive efficiencies in the business, offset by higher expenses due to BYDUREON pre-launch activities.

Research and development expenses decreased to $161.2 million for the twelve months ended December 31, 2011 from $183.1 million for the same period in 2010. The decrease reflects the favorable disposition of certain cost-sharing disputes with Lilly, partially offset by increased spending on our metreleptin lipodystrophy development program.

Collaborative profit sharing was $222.5 million for the twelve months ended December 31, 2011, compared to $257.1 million for the same period in 2010. The decrease is due to the termination of the Lilly collaboration.

Interest and other expense, net, increased to $51.9 million for the twelve months ended December 31, 2011 from $25.6 million for the same period in 2010. The increase primarily reflects increased interest expense on the Company's debt, resulting from the promissory note related to the RSO entered into in connection with the Settlement Agreement, and a loss on a fair value adjustment to a derivative asset.

Non-GAAP operating income was $25.7 million for the twelve months ended December 31, 2011 compared to a non-GAAP operating loss of $4.4 million for the same period in 2010. GAAP net loss for the twelve months ended December 31, 2011 was $543.4 million, or $3.73 per share, compared to GAAP net loss of $152.3 million, or $1.06 per share for the
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
2. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
3. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
4. Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
5. Amylin Pharmaceuticals Reports Third Quarter Financial Results
6. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
7. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
8. Amylin Pharmaceuticals to Webcast Year-End Financial Results
9. Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference
10. Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
11. Amylin Pharmaceuticals to Present at The Barclays Capital 2010 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... Salix Pharmaceuticals, Ltd. (the " Company " ... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX:VRX), ... Fundamental Changes, Make-Whole Fundamental Changes and Merger Event, Fundamental ... and Offer to Purchase (the " Notice ") to ... (the " Notes "), pursuant to the Indenture, dated ...
(Date:4/1/2015)... -- New York College of Health Professions announces a valuable ... U.S. Patent #8,996,098 donated by its Chairman under the ... instrument that allows surgeons to view and compare what ... traditional format of a slide that is used during ... thus providing the surgeon real time analysis and information. ...
(Date:4/1/2015)... , April 1, 2015  Hologic, Inc. (NASDAQ: ... holders of the 2.00% Convertible Exchange Senior Notes due ... and Wilmington Trust Company, the trustee, paying agent and ... to convert the notes.  This conversion right is subject ... notes dated as of December 10, 2007, as supplemented ...
Breaking Medicine Technology:Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 2Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 3Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 4Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 5Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 6Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 7Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 2Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 3Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2037 are Eligible to Convert 2
... Feb. 19, 2011 Genoptix, Inc. (Nasdaq: ... a memorandum of understanding ("MOU") providing for the settlement ... the Superior Court of the State of California, San ... Genoptix, Inc., Case No. 37-2011-00050762-CU-BT-NC, (2) Schwitters v. Genoptix, ...
... 18, 2011 TLC Vision announced today its plans for ... in San Diego.  Internationally recognized as leaders in field of ... Tanzer MD will lend their surgical skill and expertise to ... center will continue to be at the forefront of working ...
Cached Medicine Technology:Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 2Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 3Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 4Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 5Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 6Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 7Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 8Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 9Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 10Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 11TLC Vision Announces TLC Laser Eye Center San Diego 2
(Date:4/2/2015)... April 02, 2015 Zapable - a ... with a quick and easy means for creating professional ... week creating a buzz of excitement throughout the Internet ... the attention of HonestyFirstReviews.com’s Tiffany Hendricks, prompting her to ... Andrew and Chris Fox's new Zapable software ...
(Date:4/2/2015)... Miami, FL (PRWEB) April 02, 2015 ... Track and Field gets its start! Runners have been ... are ready to start racing. Zensah®, a premium compression ... to help ensure the athletes are benefiting from ... , Zensah® is a Miami-based company, committed to using ...
(Date:4/2/2015)... April 02, 2015 Grab your favorite latte ... all of the hottest trends with the all-new, half-hour debut ... April 8th at 7:00 AM ET/PT, 6:00 AM CT, and ... queen and marketing and product strategist Forbes Riley, Forbes ... guests as well as entrepreneurs, inventors, and innovators whose creations ...
(Date:4/2/2015)... Memphis, TN: MedixSafe Vanguard 2 is available, a full ... to meet security demands – from stocking a large ... service keeping limited narcotics from falling into the wrong ... with a wireless connection to your network and mobile ... , MedixSafe Vanguard 2 provides tracking narcotics inventory ...
(Date:4/2/2015)... 2015 IDEX Health & Science ... website featuring a simple 3-click path to purchase, ... tools, and informative distributor and customer support. Using ... in fluidics products and engineering, while exceeding customer ... website’s robust product filtering and configuration tools make ...
Breaking Medicine News(10 mins):Health News:Zapable - Review Examining Andrew and Chris Fox’s App Building Software System Released 2Health News:Zensah® Partners With Austin Track Club 2Health News:Zensah® Partners With Austin Track Club 3Health News:Forbes Living Showcases Trendsetters on Discovery Channel Transponder 2Health News:Forbes Living Showcases Trendsetters on Discovery Channel Transponder 3Health News:MedixSafe Introduces New High Tech Narcotics Security Solution - Vanguard 2 2Health News:IDEX Health & Science Launches New Website with 4000+ Products 2Health News:IDEX Health & Science Launches New Website with 4000+ Products 3
... Red Cross preparing for more storms to come, ... communities large and small, Red Cross people and supplies,are ... the devastating,tornadoes which began hitting February 5. In every ... providing shelter, feeding,victims and search and rescue workers, and ...
... Kan., Feb. 6 Mediware Information,Systems (Nasdaq: MEDW ... to,the board of directors. The Company also announced that ... 16 years of valuable,service., Mr. Coelho, age 64, ... technology consumer electronic or medical device companies. He is ...
... HILL, N.C., Feb. 6 From early ... customer feedback has,enhanced services, products and processes ... study by Best Practices, LLC,s Global Benchmarking,Council. ... is key,to better aligning the customer service ...
... Although scientists have speculated over the negative effects of ... environmental toxins may disrupt the normal growth and hormonal ... as the mycoestrogen zearalenone (ZEA) produced by the Fusarium ... have properties similar to the female reproductive hormone estrogen, ...
... 6 Rising Medical Solutions, Inc.,(Rising), a ... the Private Company Index (PCI) "Top Growth ... 2007., (Logo: http://www.newscom.com/cgi-bin/prnh/20080206/AQW030LOGO-b ), ... published by Entrex, Inc. ( http://www.entrex.net ), ...
... Henry Ford Hospital is embarking on an expanded major clinical ... radiation therapy, to determine if the combined treatment is more ... prostate cancer. , The clinical trial is part of a ... to Henry Ford to study the effectiveness of gene therapy ...
Cached Medicine News:Health News:Massive American Red Cross Tornado Relief Effort Spans Five States 2Health News:Philip Coelho Joins Mediware Board 2Health News:Philip Coelho Joins Mediware Board 3Health News:Customer Experience Conference, Feb. 25-27: Sharing New Insights on Winning Customer Loyalty 2Health News:New study suggests link between environmental toxins and early onset puberty in girls 2Health News:Rising Medical Solutions, Inc. Ranks Fifth on the Private Company Index (PCI) 'Top Growth Companies' List 2Health News:Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer 2Health News:Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer 3
CritiCool™ offers precise cooling to the programmed target temperature by applying temperature control algorithm....
Complete Cataract Competence , OPMI VISU 140 is compact, good and economical. It's everything a cataract specialist needs today....
Blood grouping tubes are available in two formulations, ACD-A, ACD-B or with a CPDA solution. Blood grouping tubes are for blood grouping determinations and also for cell preservation....
BD Vacutainer® PST™ Tubes contain spray-coated lithium heparin and a gel for plasma separation. They are used for plasma determinations in chemistry....
Medicine Products: